✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

CSPC Pharmaceutical Group Ltd

Common Name
CSPC Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
21,400
Ticker
1093
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
CSPC Pharmaceutical Group Ltd. is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacture, and commercialization of a wide array of pharmaceutical product...

CSPC Pharmaceutical Group's Financial Statements Preview

Below are the financial statements of CSPC Pharmaceutical Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in billions of CNY
2024 as of 2024-12-31
2023 as of 2023-12-31
Non-current assets
Property, plant and equipment
11.37a
10.42a
Right-of-use assets
1.13a
1.23a
Investment property
0.06a
0.06a
Goodwill
0.23a
0.23a
Intangible assets
2.61a
2.2a
Interests in associates
0.82a
0.79a
Interests in joint ventures
0.71a
0.68a
Other financial assets
2.33a
2.39a
Deferred tax assets
0.25a
0.19a
Deposits, prepayments and other receivables
0.58a
0.62a
Bank deposits
2.41a
0.74a
Current assets
Inventories
3.13a
3.14a
Trade receivables
5.16a
5.87a
Deposits, prepayments and other receivables
0.89a
0.67a
Bills receivables
4.04a
3.69a
Amounts due from related companies
0.36a
0.16a
Amounts due from joint ventures
0.07a
0.13a
Other financial assets
0.17a
0a
Structured bank deposits
1.31a
1.08a
Bank deposits, balances and cash
6.78a
12.02a
Current liabilities
Trade payables
1.67a
2.43a
Other payables
5.74a
5.98a
Contract liabilities
0.28a
0.33a
Bills payables
0.95a
0.42a
Amounts due to related companies
0.27a
0.02a
Amounts due to joint ventures
0.13a
0.04a
Lease liabilities
0.06a
0.15a
Tax liabilities
0.14a
0.38a
Bank borrowings
0.39a
0.45a
Net current assets
12.25a
16.56a
Total assets less current liabilities
34.75a
36.1a
Non-current liabilities
Other payables
0.41a
0.4a
Lease liabilities
0.06a
0.11a
Deferred tax liabilities
0.42a
0.57a
Net assets
33.87a
35.02a
Capital and reserves
Share capital
11.03a
10.9a
Reserves
21.23a
22.3a
Equity attributable to owners of the Company
32.26a
33.2a
Non-controlling interests
1.6a
1.81a
Total equity
33.87a
35.02a
Limited Data Preview
You are viewing a limited preview of CSPC Pharmaceutical Group’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind CSPC Pharmaceutical Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CSPC Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.

a. CSPC Pharmaceutical Group's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?